Synvisc
FDA premarket approval P940015/S039 · decided 2017-03-29
Approval details
- PMA number
- P940015
- Supplement
- S039
- Supplement type
- 30-Day Notice
- Supplement reason
- Process Change - Manufacturer/Sterilizer/Packager/Supplier
- Trade name
- Synvisc
- Generic name
- Acid, hyaluronic, intraarticular
- Applicant
- Sanofi Genzyme Corp.
- Date received
- 2017-02-28
- Decision date
- 2017-03-29
- Days to decision
- 29 days
- Decision code
- OK30
- Product code
- MOZ
- Advisory committee
- Orthopedic
- Expedited review
- No
- Location
- Cambridge, MA
- Statement
- Modifications to the filtration process for a component of Synvisc and Synvisc-One.
Class III intelligence, same tools
PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.